抗瘤孕激素的活性:细胞静止作用和免疫反应
T Pavlik1, E Konchekov2, N Shimanovskii3
1Pirogov Russian National Research Medical University, Russia; Prokhorov General Physics Institute of the Russian Academy of Sciences, Russia.
Steroids
|July 24, 2024
概括
孕激素可以减缓瘤生长,但可能抑制免疫反应,可能有助于癌症的传播. 然而,一些孕激素增强了自然杀手 (NK) 细胞的活性,为癌症治疗提供了希望.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
背景情况:
- 孕激素用于治疗激素敏感瘤.
- 了解它们对瘤细胞和免疫力的复杂影响至关重要.
研究的目的:
- 审查瘤细胞中的孕激素机制.
- 为了在不同类型的瘤中区分孕激素和类似物的影响.
- 评估孕激素对抗瘤免疫反应的影响.
主要方法:
- 关于孕激素作用的文献综述.
- 对孕激素和模拟效应的分析.
- 检查免疫系统的相互作用.
主要成果:
- 孕激素表现出细胞静止作用,但可以抑制抗瘤免疫力,可能促进瘤增殖和转移.
- 特定的孕激素 (dienogest,megestrol乙酸,levonorgestrel) 增加NK细胞的活动.
- NK细胞对抗瘤细胞至关重要.
结论:
- 孕激素在癌症中具有双重作用:细胞静止和免疫调节.
- 某些孕激素通过NK细胞激活来增强抗瘤免疫力.
- 现有的和新的孕激素在瘤学中显示出治疗潜力.
相关概念视频
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
501
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
501
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


